Success Metrics

Clinical Success Rate
90.9%

Based on 30 completed trials

Completion Rate
91%(30/33)
Active Trials
1(2%)
Results Posted
50%(15 trials)
Terminated
3(7%)

Phase Distribution

Ph phase_1
8
20%
Ph phase_3
3
7%
Ph phase_4
12
29%
Ph not_applicable
14
34%
Ph phase_2
4
10%

Phase Distribution

8

Early Stage

4

Mid Stage

15

Late Stage

Phase Distribution41 total trials
Phase 1Safety & dosage
8(19.5%)
Phase 2Efficacy & side effects
4(9.8%)
Phase 3Large-scale testing
3(7.3%)
Phase 4Post-market surveillance
12(29.3%)
N/ANon-phased studies
14(34.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.2%

30 of 34 finished

Non-Completion Rate

11.8%

4 ended early

Currently Active

1

trials recruiting

Total Trials

41

all time

Status Distribution
Active(1)
Completed(30)
Terminated(4)
Other(6)

Detailed Status

Completed30
unknown6
Terminated3
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
41
Active
1
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 18 (19.5%)
Phase 24 (9.8%)
Phase 33 (7.3%)
Phase 412 (29.3%)
N/A14 (34.1%)

Trials by Status

withdrawn12%
completed3073%
unknown615%
recruiting12%
terminated37%

Recent Activity

Clinical Trials (41)

Showing 20 of 41 trialsScroll for more
NCT05693246Not Applicable

Effect of Perioperative Use of Glycopyrrolate on Lung Function in Patients Under General Anesthesia

Completed
NCT05887375Phase 4

Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery

Completed
NCT05116930Phase 2

Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture

Recruiting
NCT03111121Phase 4

Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy

Completed
NCT06045364Phase 1

Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation

Completed
NCT06237478Not Applicable

Effects of Glycopyrrolate on Heart Rate and Heart Rate Variability in Patients With Different Basic Heart Rate

Completed
NCT03939923Phase 4

Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting Surgery

Completed
NCT06041984Phase 1

Antiperistaltic Effect and Safety of Glycopyrronium for Colonoscopic Polypectomy

Unknown
NCT03742141Not Applicable

Intraoperative Video Laryngoscopy as Adjunct for Nerve Monitoring

Completed
NCT03513406Phase 3

Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery

Completed
NCT05997004Not Applicable

Glycopyrrolate Prophylaxis for Prevention of Bradyarrhythmia During Laparoscopic Cholecystectomy

Completed
NCT03322657Phase 4

Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular

Completed
NCT01476813Phase 2

Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate

Completed
NCT01398111Phase 1

Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers

Completed
NCT01176903Phase 1

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration

Completed
NCT01176851Phase 1

Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy Volunteers

Completed
NCT02574611Phase 1

Use of High Resolution Colonic Manometry in Studying Motility

Withdrawn
NCT03357393Not Applicable

Patient-controlled Sedation With Propofol Versus Combined Sedation During Bronchoscopy

Completed
NCT03138967Phase 4

Investigation of Sugammadex in Outpatient Urological Procedures

Completed
NCT02524145Not Applicable

Chronotropic Incompetence in Patients With HFpEF

Completed

Drug Details

Intervention Type
DRUG
Total Trials
41